Your prediction
Pros and Cons of Aspira Womens Health Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Aspira Womens Health Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Aspira Womens Health Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | -0.770% | 1.801% | -17.992% | -58.805% | -36.580% | -66.357% | -95.128% |
| Evolus Inc | -0.560% | 2.890% | -21.586% | -60.663% | -34.679% | -51.892% | -68.214% |
| Sangamo Therapeutics Inc. | -1.650% | -15.717% | -38.107% | -65.898% | -36.993% | -85.186% | -97.618% |
Comments
Aspira Women's Health Inc. (NASDAQ: AWH) had its price target lowered by analysts at Alliance Global Partners from $7.00 to $5.50. They now have a "buy" rating on the stock.
Show more
Ratings data for AWH provided by MarketBeat
Aspira Women's Health Inc. (NASDAQ: AWH) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AWH provided by MarketBeat
